skip to content
2003 oncology nursing drug handbook Preview this item
ClosePreview this item
Checking...

2003 oncology nursing drug handbook

Author: Gail M Wilkes; Karen Ingwersen; Margaret Barton-Burke
Publisher: Sudbury, MA : Jones and Bartlett Publishers, ©2002.
Series: Jones and Bartlett series in oncology.
Edition/Format:   Print book : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Handbooks
Document Type: Book
All Authors / Contributors: Gail M Wilkes; Karen Ingwersen; Margaret Barton-Burke
ISBN: 0763721417 9780763721411
OCLC Number: 52102635
Description: xix, 1076 pages : illustrations ; 22 cm.
Contents: Section 1. Cancer Treatment. p. 1. Chapter 1. Introduction to Chemotherapy Drugs. p. 2. Acridinyl anisidide. p. 31. Adrenocorticoids. p. 34. Altretamine. p. 38. 9-Aminocamptothecin. p. 40. Aminoglutethimide. p. 42. Anastrozole. p. 44. Androgens: testosterone propionate, obfluoxymesterone, obtestolactone. p. 46. Arsenic trioxide. p. 48. Asparaginase. p. 55. 5-Azacytidine. p. 58. Bicalutamide. p. 61. Bleomycin sulfate. p. 62. Busulfan. p. 65. Busulfan for injection. p. 67. Capecitabine. p. 74. Carboplatin. p. 77. Carmustine. p. 80. Chlorambucil. p. 84. Cisplatin. p. 86. Cladribine. p. 91. Cyclophosphamide. p. 95. Cytarabine, cytosine arabinoside. p. 99. Cytarabine liposome injection. p. 103. Dacarbazine. p. 105. Dactinomycin. p. 108. Daunorubicin citrate liposome injection. p. 111. Daunorubicin hydrochloride. p. 114. Decitabine. p. 117. Docetaxel. p. 119. Doxorubicin hydrochloride. p. 127. Doxorubicin hydrochloride liposome injection. p. 131. Eniluracil. p. 138. Epirubicin HCl. p. 140. Estramustine. p. 145. Estrogens: diethylstilbestrol, ethinyl estradiol, conjugated estrogen, chlorotrianisene. p. 147. Etoposide. p. 150. Exemestane. p. 154. Floxuridine. p. 157. Fludarabine phosphate. p. 160. 5-Fluorouracil. p. 162. Flutamide. p. 164. Fulvestrant injection. p. 166. Gemcitabine. p. 168. Goserelin acetate. p. 172. Hydroxyurea. p. 175. Idarubicin. p. 178. Idoxifene. p. 181. Ifosfamide. p. 182. Irinotecan. p. 186. Karenitecin. p. 194. Ketoconazole. p. 197. Letrozole. p. 200. Leuprolide acetate. p. 202. Lomustine. p. 204. Mechlorethamine hydrochloride. p. 207. Melphalan hydrochloride. p. 210. Menogaril. p. 213. Mercaptopurine. p. 216. Methotrexate. p. 217. Methyl-CCNU. p. 221. Mitomycin. p. 224. Mitotane. p. 227. Mitoxantrone. p. 228. Nilutamide. p. 231. Oxaliplatin. p. 233. Paclitaxel. p. 235. Pamidronate disodium. p. 242. Pegasparaginase. p. 244. Pegfilgrastim. p. 247. Pentostatin. p. 250. Plicamycin. p. 255. Polifeprosan 20 with carmustine (BCNU) implant. p. 257. Procarbazine hydrochloride. p. 261. Progestational Agents: medroxyprogesterone acetate, megestrol acetate. p. 264. Raloxifene hydrochloride. p. 265. Raltitrexed. p. 268. Rebeccamycin analogue. p. 271. Rubitecan. p. 273. Streptozocin. p. 275. Tamoxifen citrate. p. 278. Temozolamide. p. 281. Teniposide. p. 284. Thioguanine. p. 287. Thiotepa. p. 289. Topotecan hydrochloride for injection. p. 291. Toremifene citrate. p. 294. Trimetrexate. p. 295. UFT. p. 298. UFT plus leucovorin. p. 300. Valrubicin. p. 302. Vinblastine. p. 304. Vincristine. p. 307. Vindesine. p. 310. Vinorelbine tartrate. p. 312. Chapter 2. Biologic Response Modifier Therapy. p. 317. Darbepoetin alfa. p. 321. Epoetin alfa. p. 325. Filgrastim. p. 327. Interferon alfa-([alpha]). p. 329. Interferon alfa-2b. p. 333. Interferon gamma. p. 337. Interleukin-2. p. 340. Interleukin-3. p. 344. Interleukin-6. p. 345. Interleukin-12. p. 347. Levamisole hydrochloride. p. 349. Megakaryocyte growth and development factor. p. 352. Novel erythropoiesis stimulating factor. p. 353. Oprelvekin. p. 354. PIXY-321. p. 357. Sargramostim. p. 358. Tumor necrosis factor. p. 361. Chapter 3. Antineoplastic Treatment Agonists: Radiosensitizers, Chemosensitizers, and Chemical Adjuncts. p. 364. Chromic phosphate P32 suspension. p. 365. Etanidazole. p. 368. Fluosol DA (20%). p. 369. Leucovorin calcium. p. 370. Porfirmer. p. 372. Tirapazamine. p. 374. Chapter 4. Cytoprotective Agents. p. 377. Allopurinol sodium. p. 381. Amifostine for injection. p. 384. . BNP7787. p. 387. . Dexrazoxane for injection. p. 389. . Glutamine. p. 390. . Mesna for injection. p. 392. Chapter 5. Molecularly Targeted Therapies. p. 394. . AG3340. p. 419. . Alemtuzumab. p. 421. . Alitretinoin gel 0.1%. p. 424. . Arasentan. p. 426. . Bevacizumab. p. 427. . Bexarotene. p. 430. . Cetuximab. p. 436. . Denileukin diftitox. p. 440. . Erlotinib. p. 445. . Gemtuzumab ozogamicin for injection. p. 448. . [superscript 90]Y ibritumomab tiuxetan. p. 452. . Imatinib mesylate. p. 455. . Neovastat. p. 459. . Rituximab. p. 460. . Thalidomide. p. 464. . Tositumomab, I[superscript 131] tositumomab. p. 467. . Trastuzumab. p. 470. . Tretinoin. p. 473. . Liposomal tretinoin. p. 477. . ZD1839. p. 481. Section 2. Symptom Management. p. 485. Chapter 6. Pain. p. 486. . Non-narcotic Analgesics. p. 494. . Acetaminophen. p. 494. . Aspirin, acetylsalicylic acid. p. 495. . Celecoxib. p. 498. . Choline magnesium trisalicylate. p. 501. . Clonidine hydrochloride. p. 503. . Gabapentin. p. 506. . Ibuprofen. p. 509. . Indomethacin. p. 512. . Ketorolac tromethamine. p. 515. . Rofecoxib. p. 519. . Salsalate. p. 522. . Narcotic Analgesics. p. 525. . Codeine. p. 525. . Fentanyl citrate. p. 528. . Fentanyl transdermal system. p. 532. . Hydromorphone. p. 536. . Levorphanol tartrate opioid. p. 540. Meperidine hydrochloride. p. 543. . Methadone. p. 548. . Morphine. p. 552. . Morphine-dextromethorphan. p. 556. . Oxycodone. p. 559. . Adjuvants Agents. . Modafinil. p. 563. Chapter 7. Nausea and Vomiting. p. 567. . Dexamethasone. p. 574. . Diphenhydramine hydrochloride. p. 576. . Dolasetron mesylate. p. 578. . Dronabinol. p. 581. . Droperidol. p. 582. . Granisetron hydrochloride. p. 584. . Haloperidol. p. 585. . Metoclopramide hydrochloride. p. 587. . Ondansetron hydrochloride. p. 589. . Perphenazine. p. 590. . Prochlorperazine. p. 592. . Promethazine hydrochloride. p. 594. . Scopolamine. p. 595. . Thiethylperazine. p. 596. Chapter 8. Anorexia and Cachexia. p. 598. . Dronabinol. p. 600. . Megestrol acetate. p. 601. . Thalidomide. p. 603. Chapter 9. Anxiety and Depression. p. 607. . Alprazolam. p. 608. . Amitriptyline hydrochloride. p. 611. . Bupropion hydrochloride. p. 613. . Buspirone hydrochloride. p. 617. . Citalopram hydrobromide. p. 618. . Clonazepam. p. 622. . Desipramine hydrochloride. p. 625. . Diazepam. p. 628. . Doxepin hydrochloride. p. 631. Fluoxetine hydrochloride. p. 633. . Imipramine pamoate. p. 637. . Lorazepam. p. 640. . Mirtazapine. p. 643. . Nefazodone HCI. p. 646. . Nortriptyline hydrochloride. p. 649. . Oxazepam. p. 652. Paroxetine hydrochloride. p. 655. Sertraline hydrochloride. p. 658. . Trazodone hydrochloride. p. 660. . Venlafaxine hydrochloride. p. 663. . Zolpidem tartrate. p. 667. Section 3 Complications. p. 671. Chapter 10. Hypercalcemia. p. 672. . Calcitonin-salmon. p. 675. . Etidronate disodium. p. 677. . Furosemide. p. 679. . Gallium nitrate. p. 681. . Pamidronate disodium. p. 683. . Zolendronate. p. 685. Chapter 11. Infection. p. 688. . Antibiotics. p. 695. . Amikacin sulfate. p. 695. . Amoxicillin. p. 699. . Ampicillin. p. 702. . Azithromycin. p. 705. . Aztreonam. p. 708. . Carbenicillin indanyl sodium. p. 711. . Cefaclor. p. 714. . Cefadroxil. p. 717. . Cefamandole nafate. p. 718. . Cefazolin sodium. p. 722. . Cefdinir. p. 726. . Cefditoren pivoxil. p. 729. . Cefepime. p. 731. . Cefixime. p. 734. . Cefoperazone sodium. p. 737. . Cefotaxime sodium. p. 739. . Cefotetan. p. 743. . Cefoxitin sodium. p. 745. . Cefpodoxime proxetil. p. 749. . Cefprozil. p. 750. . Ceftazidime. p. 752. . Ceftibuten. p. 756. . Ceftriaxone sodium. p. 758. . Cefuroxime. p. 761. . Cephalexin. p. 763. . Cephapirin. p. 765. . Cephradine. p. 767. . Ciprofloxacin. p. 771. . Clarithromycin. p. 774. . Clindamycin phosphate. p. 777. . Co-trimoxazole; trimethoprim and sulfamethoxazole. p. 780. . Dicloxacillin sodium. p. 784. . Doxycycline hyclate. p. 787. . Ertapenem. p. 790. . Erythromycin. p. 792. . Gatifloxacin. p. 795. . Gentamicin sulfate. p. 798. . Imipenem/cilastatin sodium. p. 801. . Kanamycin sulfate. p. 805. . Levofloxacin. p. 809. . Linezolid. p. 812. . Metronidazole hydrochloride. p. 814. . Mezlocillin sodium. p. 817. . Minocycline hydrochloride. p. 821. . Moxifloxacin. p. 824. . Nafcillin sodium. p. 827. . Oxacillin sodium. p. 830. . Penicillin G. p. 833. . Piperacillin sodium. p. 837. . Quinupristin and dalfopristin. p. 841. . Streptomycin sulfate. p. 843. . Ticarcillin disodium. p. 847. . Tobramycin sulfate. p. 851. Vancomycin hydrochloride. p. 854. . Antifungals. p. 858. . Amphotericin B; amphotericin B lipid complex. p. 858. . Caspofungin. p. 862. . Fluconazole. p. 864. . Flucytosine. p. 867. . Itraconazole. p. 869. . Ketoconazole. p. 871. . Miconazole nitrate. p. 874. . Nystatin. p. 876. . Antivirals. p. 878. . Acyclovir. p. 878. . Cidofovir. p. 881. . Famciclovir. p. 885. . Foscarnet sodium. p. 886. . Ganciclovir. p. 890. . Valacyclovir hydrochloride. p. 893. Chapter 12 Constipation. p. 895. . Bisacodyl. p. 896. . Docusate calcium, docusate potassium, docusate sodium. p. 897. . Glycerin suppository. p. 898. . Lactulose. p. 900. . Magnesium citrate. p. 901. . Methylcellulose. p. 902. . Mineral oil. p. 903. . Polyethylene glycol 3350, NF powder. p. 905. . Senna. p. 906. . Sorbitol. p. 908. Chapter 13. Diarrhea. p. 910. . Deodorized tincture of opium. p. 911. . Diphenoxylate hydrochloride and atropine. p. 912. . Kaolin/pectin. p. 914. Loperamide hydrochloride. p. 915. . Octreotide acetate. p. 916. Section 4. Polypharmacy. p. 921. Chapter 14 Polypharmacy. p. 922. Appendix 1. Controlling Occupational Exposure to Hazardous Drugs. p. 928. Appendix 2. National Cancer Institute Common Toxicity Criteria. p. 958. Appendix 3. Cancer Chemotherapeutic Regimes (Adult). p. 1013. . Index. p. 1063.
Series Title: Jones and Bartlett series in oncology.
Other Titles: Two thousand three oncology nursing drug handbook
Oncology nursing drug handbook
Responsibility: Gail M. Wilkes, Karen Ingwersen, Margaret Barton-Burke.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/52102635> # 2003 oncology nursing drug handbook
    a schema:CreativeWork, schema:Book ;
    library:oclcnum "52102635" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/mau> ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/1083752#Place/sudbury_ma> ; # Sudbury, MA
    schema:about <http://id.loc.gov/authorities/subjects/sh85019497> ; # Cancer--Chemotherapy
    schema:about <http://experiment.worldcat.org/entity/work/data/1083752#Topic/antineoplastic_agents_therapeutic_use> ; # Antineoplastic Agents--therapeutic use
    schema:about <http://id.worldcat.org/fast/810595> ; # Antineoplastic agents
    schema:about <http://id.worldcat.org/fast/845327> ; # Cancer--Chemotherapy
    schema:about <http://dewey.info/class/616.994/> ;
    schema:about <http://id.worldcat.org/fast/845400> ; # Cancer--Nursing
    schema:about <http://experiment.worldcat.org/entity/work/data/1083752#Topic/neoplasms_nursing> ; # Neoplasms--nursing
    schema:about <http://experiment.worldcat.org/entity/work/data/1083752#Topic/oncology_nursing_standards> ; # Oncology Nursing--standards
    schema:about <http://id.loc.gov/authorities/subjects/sh85019516> ; # Cancer--Nursing
    schema:alternateName "Two thousand three oncology nursing drug handbook" ;
    schema:alternateName "Oncology nursing drug handbook" ;
    schema:bookFormat bgn:PrintBook ;
    schema:contributor <http://viaf.org/viaf/53278993> ; # Margaret Barton-Burke
    schema:contributor <http://viaf.org/viaf/36111025> ; # Karen Ingwersen
    schema:copyrightYear "2002" ;
    schema:creator <http://viaf.org/viaf/1673664> ; # Gail M. Wilkes
    schema:datePublished "2003" ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/1083752> ;
    schema:genre "Handbooks"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/1083752#Series/the_jones_and_bartlett_series_in_oncology> ; # The Jones and Bartlett series in oncology
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/1083752#Series/jones_and_bartlett_series_in_oncology> ; # Jones and Bartlett series in oncology.
    schema:name "2003 oncology nursing drug handbook"@en ;
    schema:productID "52102635" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/52102635#PublicationEvent/sudbury_ma_jones_and_bartlett_publishers_2002> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/1083752#Agent/jones_and_bartlett_publishers> ; # Jones and Bartlett Publishers
    schema:workExample <http://worldcat.org/isbn/9780763721411> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/52102635> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1083752#Agent/jones_and_bartlett_publishers> # Jones and Bartlett Publishers
    a bgn:Agent ;
    schema:name "Jones and Bartlett Publishers" ;
    .

<http://experiment.worldcat.org/entity/work/data/1083752#Series/jones_and_bartlett_series_in_oncology> # Jones and Bartlett series in oncology.
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/52102635> ; # 2003 oncology nursing drug handbook
    schema:name "Jones and Bartlett series in oncology." ;
    .

<http://experiment.worldcat.org/entity/work/data/1083752#Series/the_jones_and_bartlett_series_in_oncology> # The Jones and Bartlett series in oncology
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/52102635> ; # 2003 oncology nursing drug handbook
    schema:name "The Jones and Bartlett series in oncology" ;
    .

<http://experiment.worldcat.org/entity/work/data/1083752#Topic/antineoplastic_agents_therapeutic_use> # Antineoplastic Agents--therapeutic use
    a schema:Intangible ;
    schema:name "Antineoplastic Agents--therapeutic use"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1083752#Topic/neoplasms_nursing> # Neoplasms--nursing
    a schema:Intangible ;
    schema:name "Neoplasms--nursing"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1083752#Topic/oncology_nursing_standards> # Oncology Nursing--standards
    a schema:Intangible ;
    schema:name "Oncology Nursing--standards"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85019497> # Cancer--Chemotherapy
    a schema:Intangible ;
    schema:name "Cancer--Chemotherapy"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85019516> # Cancer--Nursing
    a schema:Intangible ;
    schema:name "Cancer--Nursing"@en ;
    .

<http://id.worldcat.org/fast/810595> # Antineoplastic agents
    a schema:Intangible ;
    schema:name "Antineoplastic agents"@en ;
    .

<http://id.worldcat.org/fast/845327> # Cancer--Chemotherapy
    a schema:Intangible ;
    schema:name "Cancer--Chemotherapy"@en ;
    .

<http://id.worldcat.org/fast/845400> # Cancer--Nursing
    a schema:Intangible ;
    schema:name "Cancer--Nursing"@en ;
    .

<http://viaf.org/viaf/1673664> # Gail M. Wilkes
    a schema:Person ;
    schema:familyName "Wilkes" ;
    schema:givenName "Gail M." ;
    schema:name "Gail M. Wilkes" ;
    .

<http://viaf.org/viaf/36111025> # Karen Ingwersen
    a schema:Person ;
    schema:familyName "Ingwersen" ;
    schema:givenName "Karen" ;
    schema:name "Karen Ingwersen" ;
    .

<http://viaf.org/viaf/53278993> # Margaret Barton-Burke
    a schema:Person ;
    schema:familyName "Barton-Burke" ;
    schema:givenName "Margaret" ;
    schema:name "Margaret Barton-Burke" ;
    .

<http://worldcat.org/isbn/9780763721411>
    a schema:ProductModel ;
    schema:isbn "0763721417" ;
    schema:isbn "9780763721411" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.